INTRODUCTION
Apoptosis plays an essential role in the development and homeostasis of metazoans (Danial and Korsmeyer, 2004; Horvitz, 2003; Rathmell and Thompson, 2002) . The molecular mechanism of apoptosis is conserved across species. Abnormal deficiency in apoptosis is a hallmark of cancer and autoimmune diseases, whereas overactivation of apoptosis is implicated in neurodegenerative disorders (Green and Evan, 2002; Hanahan and Weinberg, 2000; Vaux and Flavell, 2000; Yuan and Yankner, 2000) . Apoptosis is executed by caspases, cysteine proteases that cleave protein substrates after aspartate residues (Thornberry and Lazebnik, 1998) .
Caspases involved in apoptosis are classified into two groups: the initiators and the effectors (Riedl and Shi, 2004) . Caspases are synthesized in cells as catalytically inactive zymogens, awaiting proteolytic activation at the onset of apoptosis. Activation of an effector caspase, such as caspase-3 or -7, is performed by a specific initiator caspase, such as caspase-8 or -9. Activation of an initiator caspase is achieved through autocatalytic cleavage, which strictly depends on the formation of an oligomeric adaptor protein complex, frequently dubbed apoptosome (Adams and Cory, 2002; Shi, 2002) . For example, the activation of caspase-2, caspase-8, and caspase-9 in mammalian cells depends on the PIDDosome (Tinel and Tschopp, 2004) , the death-inducing signaling complex (DISC) (Kischkel et al., 1995) , and the apoptosome (Cain et al., 1999; Hu et al., 1999; Rodriguez and Lazebnik, 1999; Saleh et al., 1999; Zou et al., 1999) , respectively.
As a consequence of the intrachain cleavage, the catalytic activity of an effector caspase is enhanced by several orders of magnitude . Compared to effector caspases, the activation of an initiator caspase is quite complex. Although the intrachain cleavage is essential for the activation of some initiator caspases, it has only modest effect on the catalytic activity of some other initiator caspases and may not be required for their activation (Srinivasula et al., 2001; Stennicke et al., 1999) . For example, the fully processed caspase-9 in isolation exhibits a low level of catalytic activity. The activity of caspase-9 is elevated by three orders of magnitude when it is bound to the apoptosome as a holoenzyme (Rodriguez and Lazebnik, 1999) . Thus, at least for caspase-9, activation refers to its association with the apoptosome.
Apaf-1 exists as a monomer in an autoinhibited conformation in the cytoplasm. Intracellular cell death stimuli cause the release of cytochrome c from mitochondria to the cytoplasm, where cytochrome c relieves the autoinhibition of Apaf-1 through binding and, in the presence of ATP/dATP, induces the formation of apoptosome (Cain et al., 1999; Hu et al., 1999; Li et al., 1997; Rodriguez and Lazebnik, 1999; Saleh et al., 1999; Zou et al., 1999) . The apoptosome recruits and activates the initiator caspase-9. Analysis of the apoptosome by electron cryomicroscopy revealed a wheel-shaped structure with sevenfold symmetry (Acehan et al., 2002; Yu et al., 2005) .
Apaf-1 is comprised of an N-terminal caspase recruitment domain (CARD), a central nucleotide-binding oligomerization domain (NOD), and a C-terminal region consisting of 13 WD40 repeats (Zou et al., 1997) . The WD40 repeats are believed to contribute to autoinhibition of Apaf-1, and the binding of cytochrome c to this region was shown to accelerate the binding of ATP/dATP (Jiang and Wang, 2000) . The structure of a WD40-deleted, autoinhibited Apaf-1 (hereafter referred to as Apaf-1DC) revealed, unexpectedly, that the bound nucleotide is ADP, which is deeply buried and serves as an organizing center to strengthen interactions among four adjoining subdomains . Structural analysis suggests that exchange of ADP by ATP may induce significant conformational changes in Apaf-1 and that these conformational changes may drive the formation of the caspase-9-activating apoptosome .
Despite its importance, regulation of apoptosome assembly is poorly understood. In principle, any cellular factor that affects the binding of cytochrome c to Apaf-1 or nucleotide exchange of Apaf-1 could play an important role in the regulation of apoptosome assembly. However, the only such cellular factor identified is the oncoprotein prothymosin-a, which was shown to negatively regulate caspase-9 activation by inhibiting apoptosome formation, although how this is accomplished remains unclear (Jiang et al., 2003) .
Intracellular calcium concentration is critical to various cellular processes, including cell proliferation and apoptosis (Berridge et al., 2003; Parekh and Penner, 1997; Santella, 1998) . The switch between cell proliferation and death depends on the spatial and temporal organization of calcium entry and concentration (Fanelli et al., 1999; Lang et al., 2000 Lang et al., , 2005 . While overwhelming evidence suggests that cytosolic calcium activity plays a significant role in the regulation of cell death, the causality is poorly documented. In this article, we report the finding that calcium regulates Apaf-1-dependent apoptotic pathway by interfering with the assembly of apoptosome and discuss the associated implications.
RESULTS

Assembly and Validation of Apoptosome
To investigate the regulation of apoptosome assembly, we reconstituted the Apaf-1 apoptosome using homogenous recombinant proteins. The full-length human Apaf-1 protein (residues 1-1248) was produced from baculovirus expression system and purified to homogeneity ( Figure 1A ). Apaf-1DC (residues 1-591) and the full-length human procaspase-9 (residues 1-416) were overexpressed in E. coli BL21 (DE3) and purified to homogeneity ( Figure 1A ). Procaspase-9 was autoprocessed during bacterial (A) Caspase-9 activity was assayed by cleavage of the fluorogenic substrate LEHD-AMC. The cleavage was monitored by fluorescence spectrophotometer. The purity of recombinant Apaf-1 and caspase-9 proteins was shown on the left (SDS-PAGE stained by Coomassie blue). (B) Caspase-9 is activated by the assembled apoptosome, but not by the isolated Apaf-1 protein. For the apoptosome involving the fulllength Apaf-1 protein, both cytochrome c and dATP were required for the activation of caspase-9. For the miniapoptosome involving Apaf-1DC, only dATP, but not cytochrome c, was required for caspase-9 activation. All error bars are standard deviations.
overexpression, which led to the generation of two fragments: one corresponding to residues 1-315 (35 kDa) and the other corresponding to residues 316-416 (11 kDa) ( Figure 1A ). Cytochrome c was purchased from Sigma and further purified. Apaf-1 was incubated with cytochrome c in the presence of dATP to allow the assembly of the apoptosome (see Experimental Procedures for details).
Next, we monitored caspase-9 activity using fluorogenic substrate LEHD-AMC ( Figure 1A ). As anticipated, caspase-9 was activated significantly only by the assembled apoptosome, but not by the isolated Apaf-1 protein ( Figures 1A and 1B) . For the full-length Apaf-1, both cytochrome c and dATP were indispensable for the formation of the caspase-9-activating apoptosome ( Figure 1B) . Incubation of Apaf-1DC with dATP resulted in the formation of a miniapoptosome independent of cytochrome c . The miniapoptosome also activated caspase-9 ( Figure 1B ). For Apaf-1DC, only dATP, but not cytochrome c, was required for the formation of the caspase-9-activating miniapoptosome ( Figure 1B ). As previously reported , the full-length Apaf-1 and Apaf-1DC were approximately equivalent in their ability to activate procaspase-9 ( Figure 1B ).
Calcium Interferes with Procaspase-9 Activation
Previous studies of calcium signaling suggest a critical role of calcium in cell death pathways (Demaurex and Distelhorst, 2003; Fanelli et al., 1999; Lam et al., 1994) . To define the mechanistic basis of calcium signaling in cell death, we investigated the potential effect of calcium on apoptosome-mediated caspase-9 activation. Surprisingly, preincubation of 1 mM calcium chloride with Apaf-1, prior to its incubation with cytochrome c and dATP, resulted in pronounced inhibition of its ability to activate caspase-9 in the presence of cytochrome c and dATP (Figure 2A , lanes 3 and 4). Subsequent treatment with an excess amount (5 mM) of the chelating agent ethylenediaminetetraacetic acid (EDTA) reversed the inhibition (lane 5). This effect appeared to be specific, because neither 1 mM magnesium chloride nor 1 mM manganese chloride exhibited any significant effect (Figure 2A , lanes 6 and 7). Identical results were obtained for Apaf-1DC (Figure 2A, lanes 10-14) .
To further confirm these findings, a catalytic mutant (C163A) of procaspase-3, the physiological substrate of caspase-9, was employed to examine caspase-9 activation by apoptosome in the absence and presence of calcium ion ( Figure 2B ). The use of the catalytic mutant of procaspase-3 as the substrate was designed to eliminate any potential self-cleavage that may complicate the interpretation of experimental results. As judged by the cleavage of procaspase-3 into the p20 and p12 subunits, 1 mM calcium chloride effectively blocked caspase-9 activation by Apaf-1 ( Figure 2B , lane 5); removal of calcium by EDTA restored caspase-9 activation by Apaf-1 (lane 6). In contrast, neither 1 mM magnesium chloride nor 1 mM manganese chloride had any detectable effect on caspase-9 activation (lanes 7 and 8).
These observations suggest that calcium reversibly inhibits the activation of caspase-9. To further define this process, we titrated calcium concentrations in this assay. For the full-length Apaf-1, 1 mM and 1 mM calcium chloride led to the inhibition of caspase-9 activation by 30% and 85%, respectively ( Figure 2B, lanes 4 and 8) . For Apaf-1DC, these values were 20% and 95%, respectively ( Figure 2B, lanes 11 and 14) . These experiments indicated that micromolar concentrations of calcium partially inhibited caspase-9 activation while millimolar concentrations were sufficient for nearly complete inhibition. During physiological activities, cellular calcium concentrations can reach tens or even hundreds of micromolar (Berlin et al., 1994; Daub and Ganitkevich, 2000; Rizzuto and Pozzan, 2006) . It is conceivable that such calcium sparks may directly interfere with caspase-9 activation.
Calcium Inhibits Caspase-9 Activation by Blocking Apoptosome Assembly There are two possibilities by which calcium can block caspase-9 activation. One is to inhibit the assembly of apoptosome and the other is to inhibit caspase-9 activation after apoptosome assembly. To differentiate between these two possibilities, we examined whether calcium can inhibit caspase-9 activation by the preassembled apoptosome. The result was unambiguous-1 mM calcium failed to inhibit caspase-9 activation by either the apoptosome ( Figure 3A , lanes 3 and 4) or the miniapoptosome (lanes 7 and 8). These observations strongly suggested that calcium must negatively affect the assembly of the apoptosome. These experiments also ruled out the possibility that calcium may block recruitment of caspase-9 by the apoptosome or directly inhibit caspase-9 maturation and activity.
To obtain direct evidence that calcium blocks apoptosome formation, we monitored apoptosome assembly by gel filtration chromatography ( Figures 3B-3D ). The full-length Apaf-1 assembled into an apoptosome in the presence of cytochrome c and dATP, which exhibited an apparent molecular weight in excess of 1 MDa (Figure 3B , green line). Preincubation of Apaf-1 with 1 mM calcium chloride prior to incubation with cytochrome c and dATP resulted in significantly compromised assembly of the apoptosome, as shown by the greatly diminished apoptosome fraction ( Figure 3B , blue line). An excess amount of EDTA (5 mM) was sufficient to reverse the inhibition of apoptosome formation by calcium ( Figure 3B , red line).
Identical results were obtained for the miniapoptosome. Preincubation of Apaf-1DC with 1 mM calcium chloride prior to incubation with dATP resulted in significantly compromised assembly of the miniapoptosome ( Figure 3C , blue line). Consistent with earlier observations ( Figure 3A) , incubation of Apaf-1DC with calcium after preincubation with dATP had no impact on the assembly of miniapoptosome ( Figure 3C , black line). An excess amount of EDTA (5 mM) was sufficient to counter the inhibition of miniapoptosome formation by calcium ( Figure 3C , red line). Assembly of apoptosome appeared to be a slow process, and complete assembly required overnight incubation at 4 C of the full components ( Figures 3B and 3C ).
Finally, we investigated the effect of various calcium concentrations on the assembly of the miniapoptosome ( Figure 3D ). In the absence of calcium chloride, incubation (A) Calcium, but not magnesium or manganese, inhibits the activation of caspase-9 by the apoptosome or the miniapoptosome. This inhibition is specifically relieved by an excess amount of EDTA. A fluorogenic caspase-9 substrate, LEHD-AMC, was used in this assay. (B) A repeat of experiments described in (A) using procaspase-3 (C163A) as the substrate. The full-length Apaf-1 protein was used in this assay. (C) Calcium inhibits the formation of apoptosome and miniapoptosome in a concentration-dependent manner. One micromolar calcium resulted in 20%-30% inhibition of apoptosome assembly, whereas 1 mM led to near complete inhibition. All error bars are standard deviations.
of Apaf-1DC with dATP for 30 min at 4 C converted 40% of the monomeric Apaf-1DC protein into the miniapoptosome ( Figure 3D , red line). At as low as 1 mM calcium chloride, assembly of the miniapoptosome was reduced by about 25% ( Figure 3D , green line). At 1 mM calcium chloride, nearly complete inhibition of miniapoptosome assembly was achieved ( Figure 3D , black line). These results are consistent with the extent of inhibition for caspase-9 activation ( Figure 2B ). Similar dependence on calcium concentrations was obtained for the assembly of the apoptosome (data not shown).
The above observations demonstrate that calcium inhibits caspase-9 activation by blocking the monomeric Apaf-1 protein from assembling into the apoptosome in the presence of cytochrome c and dATP. Calcium does not affect caspase-9 activation by the assembled apoptosome. (C) Preincubation with calcium significantly undermines the ability of Apaf-1DC to form a miniapoptosome in the presence of dATP. Calcium does not appear to have an apparent effect on the disassembly of the miniapoptosome. (D) Concentration-dependent effect of calcium on the assembly of the miniapoptosome. Compared to the absence of calcium, 1 mM calcium resulted in 25% inhibition of miniapoptosome assembly, whereas 1 mM led to nearly complete inhibition.
Calcium Blocks Apoptosome Assembly by Interfering with Nucleotide Exchange
Our results strongly suggest that calcium may directly bind to the monomeric Apaf-1 protein. To examine this scenario, we measured the binding affinity of calcium for Apaf-1DC using isothermal titration calorimetry (ITC). Concentrated Apaf-1DC was titrated by calcium chloride prepared in the same buffer. The heat of calcium chloride dilution was corrected using the data obtained from calcium chloride titration into the blank ITC buffer. Due to limited solubility of Apaf-1DC, the protein could only be concentrated to about 50 mM. Fitting of the titration curve gave rise to a dissociation constant of 19.3 ± 11.6 mM ( Figure 4A ). This binding strength is consistent with the observed effect on caspase-9 activation (Figure 2 ) and apoptosome formation (Figure 3) .
We asked why calcium binding to Apaf-1 results in the inhibition of apoptosome formation. One possibility is that calcium chloride inhibits the exchange of ADP/ dADP, which is bound to the monomeric Apaf-1 , by ATP/dATP, which is required for formation of the apoptosome (Li et al., 1997) . To ascertain this scenario, we quantitatively determined the identity of the nucleotides that were bound to Apaf-1DC following its incubation with various nucleotides in the presence or absence of calcium chloride. Using liquid chromatographytandem mass spectrometry (LC-MS/MS), we confirmed that the vast majority (98%) of the bound nucleotides in the untreated Apaf-1DC were ADP ( Figure 4B , lane 1). This result likely reflects a combination of the nucleotide affinity of untreated Apaf-1 and the profile of free nucleotides in E. coli cells. In the absence of calcium chloride, incubation of Apaf-1DC with 1 mM dADP led to the exchange of the vast majority of ADP for dADP, with 99% of total bound nucleotide being dADP and 1% being ADP ( Figure 4B, lane 2) . In contrast, the presence of 1 mM calcium chloride greatly diminished this exchange, resulting in only 12% of total bound nucleotide being dADP and 88% being ADP ( Figure 4B, lane 3) .
Next, we examined the exchange of ADP in Apaf-1DC by dATP, both in the presence and absence of calcium chloride ( Figure 4B, lanes 4 and 5) . In the presence of calcium chloride, exchange of ADP for dATP was also significantly compromised ( Figure 4B, lane 4) . Interestingly, 10% of Apaf-1DC contained dADP, rather than dATP ( Figure 4B, lane 4) ; we believe that this is due to hydrolysis of dATP following its exchange into Apaf-1DC. Under this condition, no assembly of miniapoptosome was detected by gel filtration. In the absence of calcium chloride, incubation of Apaf-1DC with dATP resulted in time-dependent formation of the miniapoptosome (as shown in Figure 3D ). The oligomeric Apaf-1DC (miniapoptosome) and the monomeric Apaf-1DC were separated by gel filtration chromatography and individually subjected to analysis by LC-MS/MS. The result showed that 96% of the oligomeric Apaf-1DC contained dATP whereas the monomeric Apaf-1DC contained a mixture of ADP (67%), dADP (26%), and dATP (7%) ( Figure 4B , lane 5).
To provide additional evidence for the inhibitory role of calcium in apoptosome assembly, we examined the time course of nucleotide exchange in Apaf-1DC ( Figure 4C ). Following incubation with 1 mM dADP, the bound nucleotide in Apaf-1DC was analyzed by LC-MS/MS at various time points. The result unequivocally shows that calcium effectively inhibits the nucleotide exchange process in Apaf-1DC ( Figure 4C) .
Finally, we examined the full-length Apaf-1 protein that was expressed in insect cells and purified to homogeneity. Using LC-MS/MS, we found that the bound nucleotides in the untreated full-length Apaf-1 protein were predominantly ADP, with no detectable levels of any other nucleotide ( Figure 4D, lane 1) . This result is similar to that of Apaf-1DC derived from recombinant expression in bacteria ( Figure 4B , lane 1) and is consistent with our structural finding . However, this result differs from another published paper (Kim et al., 2005) , in which the full-length Apaf-1 protein was reported to contain dATP. The full-length Apaf-1 was incubated with 1 mM dADP in the absence or presence of 1 mM calcium chloride. The results showed that 87% of bound ADP was replaced by dADP in the absence of calcium, whereas only 3% of bound ADP was replaced by dADP in the presence of calcium ( Figure 4D, lanes 2 and 3) . Together, the above experiments indicate that calcium chloride inhibits the assembly of apoptosome at least in part by interfering with nucleotide exchange in Apaf-1.
Effect of Calcium on the Conformation of Apaf-1 Calcium binding is predicted to have an impact on the conformation of Apaf-1. The crystal structure of Apaf-1DC showed that the bound ADP molecule is buried and inaccessible to even small molecules unless the conformation is perturbed . The observed nucleotide exchange between ADP and dADP ( Figure 4) suggests that some conformational change such as ''breathing motion'' may accompany this process. The fact that calcium binding to Apaf-1 interferes with nucleotide exchange implies that calcium is likely to inhibit this conformational change. In other words, calcium binding may stabilize a specific conformation of Apaf-1, hereafter referred to as the closed form (because this conformation is resistant to nucleotide exchange). To provide experimental evidence for this scenario, we tested whether limited proteolysis could differentiate the calcium-bound conformation of Apaf-1 from that of the free Apaf-1.
The full-length Apaf-1 and Apaf-1DC were individually subjected to limited proteolysis by trypsin in the absence or presence of 1 mM calcium chloride ( Figures 5A and 5B) . The digestion patterns were influenced strongly by calcium. For both proteins, the presence of calcium led to the generation and persistence of a 40 kDa fragment that appeared to be quite resistant to trypsin digestion ( Figures 5A and 5B ). In contrast, this fragment was sensitive to trypsin cleavage in the absence of calcium. To rule out the possibility that the altered digestion patterns were simply caused by calcium effect upon trypsin, another protein, DIAP-1, which does not bind calcium, was digested by trypsin in the presence and absence of calcium. The digestion patterns were virtually identical between the two conditions (data not shown).
To provide additional evidence for calcium-dependent conformations in Apaf-1, we examined digestion patterns of Apaf-1DC using three other proteases, chymotrypsin, elastase, and papain, which have different substrate specificity and are expected to give distinct cleavage patterns. In all three cases, the digestion patterns of Apaf-1DC in the presence of calcium are different from those in the absence of calcium ( Figure 5C and data not shown). For example, the generation and persistence of a 50 kDa fragment by elastase treatment are only associated with the presence of calcium but not its absence ( Figure 5C , left). In contrast, the digestion patterns of DIAP-1 by any of these proteases exhibited no apparent differences with or without calcium (data not shown). Together, these observations suggest that calcium binding may stabilize the closed conformation of Apaf-1, rendering it more resistant to limited proteolysis.
DISCUSSION
In this study, we report the finding that calcium inhibits caspase-9 activation by blocking the assembly of apoptosome ( Figure 6 ). Calcium directly binds to Apaf-1, and this binding inhibits nucleotide exchange in Apaf-1, which is required for apoptosome assembly. The calcium-binding affinity of Apaf-1 (19.3 mM) is consistent with a regulatory role for calcium, as calcium concentrations range from a few to hundreds of micromolars in cells (Berlin et al., 1994; Daub and Ganitkevich, 2000; Rizzuto and Pozzan, 2006) .
One unanswered question is exactly where calcium binds in the Apaf-1 structure. Although a precise answer to this question requires a high-resolution crystal structure of Apaf-1 in the presence of calcium, the current study revealed tantalizing clues. Comparison of the trypsin digestion patterns of Apaf-1 in the presence and absence of calcium suggests that calcium binding stabilizes a 40 kDa fragment that is common to the full-length Apaf-1 and Apaf-1DC. This knowledge, together with information on the nucleotide-binding pocket , identifies the region adjoining four subdomains of Apaf-1DC as the likely candidate for calcium binding. By binding to this region, calcium would strengthen the intradomain interactions, thus making nucleotide exchange more difficult. This hypothesis is also supported by the proteolysis patterns using chymotrypsin and elastase, both of which resulted in the accumulation of an Apaf-1 fragment of at least 40 kDa ( Figure 5C, arrows) . Interestingly, once Apaf-1 assembles into the apoptosome, calcium does not have an apparent effect on the disassembly of the apoptosome ( Figure 3C ). This observation suggests that, compared to the Apaf-1 monomer, Apaf-1 molecules in the apoptosome likely exhibit a different conformation that no longer contains the binding pocket for calcium.
In this study, we employed Apaf-1DC derived from bacterial expression and the full-length Apaf-1 protein expressed in Hi-5 insect cells. Using LC-MS/MS, we quantitatively identified the bound nucleotides to be predominantly ADP in both Apaf-1DC and the full-length Apaf-1 protein (Figure 4) . These results are consistent with our previous structural observation, where ADP was found to be associated with Apaf-1DC . On the basis of these observations, we propose that the bound nucleotide in monomeric Apaf-1 is likely to be ADP ( Figure 6 ). However, these observations are different from a published report, in which the monomeric, fulllength Apaf-1 protein derived from Sf-21 insect cells was found to contain dATP using LC-MS (Kim et al., 2005) . Although we do not know exactly what factors contribute to the discrepancy, we speculate that it could be due to differences in protein expression, purification, and/or handling. It is possible that the local cellular concentrations of various nucleotides differ in different protein expression systems and are dependent upon the metabolic states of the insect cells. Another possibility is that some unidentified cellular factor(s) in one of the expression systems or handling of the recombinant protein in vitro stimulates or inhibits the hydrolysis of the bound ATP/dATP in newly synthesized Apaf-1. Nonetheless, it is important to note that, in the published study (Kim et al., 2005) , dATP in the monomeric Apaf-1 was hydrolyzed and the resulting dADP must be exchanged out by dATP in order for the apoptosome to assemble. Thus, nucleotide exchange is essential for apoptosome formation in both studies. In this regard, the discrepancy in terms of the initial identity of the bound nucleotide in the monomeric Apaf-1 protein does not affect the major conclusion of this study-calcium blocks apoptosome formation by inhibiting nucleotide exchange in Apaf-1.
The exchange of ADP by dATP in the monomeric Apaf-1 protein is shown to be essential for the formation of the caspase-9-activating apoptosome. Importantly, the nucleotides in the apoptosome are predominantly dATP ( Figure 4B and data not shown). These observations indicate that hydrolysis of dATP is not required for the formation of the apoptosome or activation of caspase-9. This conclusion agrees with published reports (Jiang and Wang, 2000; Kim et al., 2005) but contradicts a previous finding that EDTA inhibited Apaf-1-mediated caspase-9 activation . We have scrutinized the experimental conditions used in the previous study and found that the concentration of the previously used EDTA stock solution was in error. Indeed, very high concentrations of EDTA (>10 mM) did not affect the formation of the apoptosome but inhibited apoptosomemediated caspase-9 activity through unknown mechanisms (data not shown).
Incubation of the monomeric Apaf-1DC with dATP in the absence of calcium led to time-dependent formation of miniapoptosome ( Figure 3D ). The monomeric and oligomeric Apaf-1DC were fractionated by gel filtration and analyzed by LC-MS/MS ( Figure 4B, lane 5) . Interestingly, while the oligomeric Apaf-1DC (miniapoptosome) contains predominantly dATP, the monomeric Apaf-1DC contains a mixture of ADP (67%), dADP (26%), and dATP (7%) ( Figure 4B , lane 5). Because only 2% of the bound nucleotides in the untreated Apaf-1DC were dADP ( Figure 4B , lane 1), the presence of dADP in 26% of the bound nucleotides in the treated, monomeric Apaf-1DC strongly suggests that the majority of bound dADP was a result of hydrolysis of dATP by Apaf-1DC.
The decision for a cell to undergo apoptosis is tightly regulated. As the central hub of cellular metabolism and one of the major matrices that buffer calcium, mitochondria play a pivotal role in this decision-making process (Wang, 2001) . A body of biochemical and structural studies has already revealed multiple layers of regulation of the mitochondria-mediated apoptotic pathway. One layer of regulation is activation of Apaf-1, which remains dormant in the cytoplasm prior to the arrival of cell death stimulus. The C-terminal WD40 repeats of Apaf-1 function like a safety lock to prevent its oligomerization until the release of cytochrome c from mitochondria. Another layer of regulation is mitochondrial permeability, which is controlled by the Bcl-2 family of proteins (Wang, 2001) . A third layer of regulation is activation of caspases, which are synthesized as inactive zymogens and must undergo proteolytic activation. The observations from this study suggest a fourth layer of regulation in the Apaf-1-dependent apoptotic pathway and identify calcium as a critical regulator of apoptosome assembly ( Figure 6 ). Our in vitro study explicitly shows that the monomeric Apaf-1 protein binds to calcium and adopts an unproductive conformation that fails to oligomerize in the presence of cytochrome c and dATP. However, calcium does not have any significant effect on the assembled apoptosome or caspase-9 activation. These findings strongly suggest a link between intracellular calcium concentrations and the initiation of intrinsic apoptotic pathway in vivo.
Ample evidence points to a critical role of cytosolic calcium in the regulation of cell proliferation and cell death (Berridge et al., 2003; Parekh and Penner, 1997; Santella, 1998) . Growth factors are known to stimulate calcium entry and trigger subsequent calcium oscillations in proliferating cells (Munaron et al., 2004; Parekh and Putney, 2005) . Elevated intracellular calcium concentration is associated with progression through the cell cycle (Schreiber, 2005) . It is intriguing to hypothesize that in actively proliferating cells, spikes of higher intracellular calcium concentration preemptively rest Apaf-1 in an unproductive conformation such that no apoptosome will be assembled even in the case of minor mitochondria leakage, under which condition some cytochrome c molecules are accidentally released into the cytoplasm. This might also be the case for some postmitotic cells, such as neurons and cardiomyocytes, which tend to have higher intracellular calcium concentration Potts et al., 2003) . These cells are not readily susceptible to death induced by the introduction of cytochrome c into the cytoplasm (Neame et al., 1998) . Their limit in regeneration capability increases the cost of unnecessary apoptosis. Increased calcium concentration might be an effective method to increase the threshold for the initiation of the apoptotic pathway.
Studies of apoptotic and excitotoxic neuron death also provided multiple lines of evidence supporting a link between calcium homeostasis and cell death. Pathophysiological calcium overloading is implicated in neurodegeneration after stroke, cerebral trauma, and epileptic seizures (Choi, 1994) . When the cytosolic calcium concentration reaches a set point, calcium is taken up by mitochondria via calcium uniporter (Duchen, 2000; Nicholls and Akerman, 1982) . There is evidence that mitochondrial calcium overloading triggers cell death by opening the permeability transportation pore complex (Chinopoulos and Adam-Vizi, 2006; Nicholls and Budd, 2000; Stout et al., 1998) , through which proapoptotic factors, including cytochrome c, are released into the cytoplasm. A delayed, irreversible rise in cytosolic calcium concentration, the so-called delayed calcium deregulation (DCD), will ensue in the neuron cells that are committed to death. Some studies suggest this type of cell death is caspase independent, as addition of pancaspase inhibitors does not rescue the cells (Lankiewicz et al., 2000; Wolf et al., 1999) . It is possible, albeit unproven, that Apaf-1 protein levels are normal in these cells and Apaf-1 fails to oligomerize in the presence of dATP and cytochrome c due to elevated calcium concentrations.
EXPERIMENTAL PROCEDURES
Protein Preparation and Materials
Recombinant Apaf-1DC (residues 1-591) was expressed and purified as described . Procaspase-9 was expressed and purified as described . Recombinant full-length Apaf-1 was expressed in baculovirus-infected Hi-5 insect cells at 27 C for 60 hr and purified largely as described (Jiang and Wang, 2000) . Nucleotides dATP, ATP, dADP, and ADP were purchased from Sigma. Calcium chloride, magnesium chloride, potassium chloride, and EDTA were purchased from Aldrich. Cytochrome c from bovine heart was purchased from Sigma.
Assembly of Apoptosome
For the assembly of apoptosome, Apaf-1 was incubated with 100 mM cytochrome c in the presence of 1 mM dATP at 4 C overnight or at 22 C for 10 min. To allow nearly complete assembly of miniapoptosome, Apaf-1DC was incubated with 1 mM dATP at 4 C overnight or at 22 C for 10 min. Assembly of apoptosome was considerably faster at 22 C than at 4 C. However, the assembled apoptosome exhibited a low solubility at 22 C and precipitated out of solution. For this reason, assembly of apoptosome was performed at 4 C overnight for gel filtration experiments, which require high concentrations of apoptosome, and at 22 C for 10 min for caspase-9 assays, which only need low concentrations of apoptosome.
Caspase-9 Activation Assay
The reaction was performed at 25 C in an assay buffer containing 20 mM HEPES (pH 7.0), 100 mM NaCl, and 5 mM DTT. To a final volume of 200 ml, a final concentration of 2 mM Apaf-1, indicated amount of CaCl 2 , 1 mM dATP, 10 mM cytochrome c, and 0.2 mM procaspase-9 were added accordingly for 10 min incubation at 22 C before the caspase-9 substrate LEHD-AMC was added to the reaction at a final concentration of 200 mM. The conversion of the fluorogenic substrate was monitored by a Hitachi F2500 fluorescence spectrophotometer using an excitation wavelength of 380 nm and an emission wavelength of 440 nm. When Apaf-1DC was assayed, cytochrome c was omitted from the reaction. Caspase-9 activation by Apaf-1 was also measured by monitoring the cleavage of its physiological substrate procaspase-3. The reaction was performed at 37 C in an assay buffer containing 10 mM HEPES (pH 7.0), 100 mM NaCl, and 5 mM DTT. To ensure that the cleavage was a direct readout of caspase-9 activity, a catalytic mutant form of procaspase-3 (C163A) was used. All components were diluted to specified concentrations using the assay buffer. Reactions were stopped after 120 min by adding an equal volume of SDS-loading buffer. The results were visualized by SDS-PAGE and Coomassie staining.
Gel Filtration Assay
Gel filtration analysis was performed using a Superdex 200 column (GE Healthcare) and Superose 6 column (GE Healthcare) at 4 C. The buffer contains 10 mM HEPES (pH 7.5), 100 mM NaCl, and 2 mM DTT. To each injection volume of 500 ml, a final concentration of 20 mM Apaf-1, indicated amount of CaCl 2 , 1 mM dATP, and 100 mM cytochrome c were added accordingly for incubation at 4 C for either overnight ( Figures 3B and 3C ) or 30 min ( Figure 3D ). When Apaf-1DC was assayed, cytochrome c was omitted from the reaction.
Isothermal Titration Calorimetry
ITC experiments were carried out using a VP-ITC (Microcal LLC) device with 20-50 mM Apaf-1DC in a buffer of 10 mM HEPES (pH 7.5) and 100 mM NaCl. After thermal equilibration at 4 C and an initial 60 s delay, 30 serial injections of 10 ml of 500 mM CaCl 2 in the same buffer were titrated into the protein solution every 200 s. In order to correct the experimental binding isotherm for background heat effects, CaCl 2 -containing buffer was also titrated into assay buffer. All corrected curves were fitted using the software Origin (Microcal LLC).
Preparation of Samples for LC-MS/MS
Protein samples were mixed with 100% acetonitrile in a 2:3 volume ratio and incubated on ice for 10 min. Denatured protein was removed by centrifugation at 14,000 rpm for 5 min at 4 C. The supernatant was then submitted to LC-MS/MS analysis immediately.
Liquid Chromatography-Tandem Mass Spectrometry LC-electrospray ionization-MS/MS was performed on a Finnigan TSQ Quantum Ultra triple quadruple mass spectrometer (Thermo Electron Corporation, San Jose, CA), coupled with an LC-10A HPLC system (Shimadzu, Columbia, MD). Compounds were detected in selected reaction monitoring (SRM) mode. SRMs (all negative ion mode) were as follows: ADP, m/z 426/134 at 24 eV; dADP, m/z 410/159 at 25 eV; ATP, m/z 506/408 at 21 eV; and dATP, m/z 490/159 at 27 eV. The MS parameters were as follows: spray voltage 3000V, nitrogen as sheath gas at 30 psi and auxiliary gas at 20 psi, argon as the collision gas at 1.5 mTorr, and capillary temperature of 325 C. Scan time for each SRM was 0.1 s with a scan width of 1 m/z. As the nucleotides of interest can be distinguished by mass spectrometry, the primary purpose of the LC separation was to separate them from compounds that might interfere with electrospray ionization, such as salt. LC was performed on an aminopropyl column (Luna 5 mm particle size, 50 3 2 mm, from Phenomenex, Torrance, CA) at basic pH (Bajad et al., 2006) . Solvent A was 20 mM ammonium acetate + 20 mM ammonium hydroxide in 95:5 water:acetonitrile (pH 9.3). Solvent B was acetonitrile. The gradient was as follows: t = 0, 85% B; t = 6 min, 0% B; t = 15 min, 0% B; t = 16 min, 85% B; and t = 20 min, 85% B. Other LC parameters were as follows: autosampler temperature of 4 C, column temperature of 15 C, injection volume of 10 ml, and solvent flow rate of 200 ml/min. Absolute quantitation of nucleotides in the biological samples was obtained through external calibration by running a series of ADP/ dADP/ATP/dATP standard mixtures at different concentrations. Briefly, a total of six standard mixtures were made, containing each nucleotide at a concentration of 0.5, 1, 2, 3, 4, and 5 mg/ml. The standard curves were linear (R R 0.995). The concentrations of nucleotides in the biological samples were obtained by normalizing to the standard curve; in cases where the observed signal was less than the limit of detection of the assay, the level was taken to be the limit of detection. Each biological condition involved duplicate independent samples. The median relative standard deviation of replicate measurements was 7%.
To guard against possible systematic errors due to calcium or other buffer components causing ion suppression, all the standards and samples had isotopic-labeled ATP (>98% 13 C, >98% 15 N, Medical Isotopes, Pelham, NH; SRM m/z 521/423 at 21 eV) at 1 mg/ml as internal standard; no systematic variation in the internal standard was observed.
